Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia
1982424 citationsJoseph DeSimone, Paul Heller et al.New England Journal of Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Paul Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Heller more than expected).
This network shows the impact of papers produced by Paul Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Heller. The network helps show where Paul Heller may publish in the future.
Co-authorship network of co-authors of Paul Heller
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Heller.
A scholar is included among the top collaborators of Paul Heller based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Paul Heller. Paul Heller is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Bhoopalam, Nirmala, Vincent Yakulis, Dario Giacomoni, & Paul Heller. (1976). Surface immunoglobulins of lymphocytes in mouse plasmacytoma. IV. Evidence for the persistence of the effect of plasmacytoma-RNA on the surface immunoglobulins of normal lymphocytes in vivo and in vitro.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(1). 139–48.6 indexed citations
7.
Heller, Paul. (1973). Once more: the pathogenic effects of the sickle cell trait.. PubMed. 225(8). 987–8.7 indexed citations
8.
Heller, Paul, et al.. (1972). Surface immunoglobulins on circulating lymphocytes in mouse and human plasmacytoma.. PubMed. 85. 192–202.10 indexed citations
Costea, Nicolas, Vincent Yakulis, & Paul Heller. (1971). The mechanism of indction of cold agglutinins by mycoplasma pneumoniae.. PubMed. 106(3). 598–604.21 indexed citations
L, Singer, et al.. (1962). A new variant of hemoglobin M disease: hemoglobin M-Chicago.. PubMed. 59. 918–25.31 indexed citations
20.
Heller, Paul, et al.. (1962). Immunologic studies of human hemoglobins.. PubMed. 59. 401–11.16 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.